Endocrine oncology

Predictors of Long-Term Fatigue in Patients with Differentiated Thyroid Cancer: A Nationwide Prospective Study

ThyroidPublished Prospective cohort study

Authors' conclusion

This study found several predictors of long-term fatigue in DTC patients. One year after treatment, fatigue and poor mental health are particularly important predictors of long-term fatigue. TSH suppression does not explain fatigue in DTC patients.

Study context

Population
Differentiated thyroid cancer (DTC) patients treated with thyroidectomy and planned for radioiodine treatment, 2012–2017, Sweden
Participants
351 patients
Outcome
Fatigue (SF-36 vitality subscale) 5 years after DTC treatment, predicted by variables measured at 1 year
Follow-up
5 years
Methodological detailsnationwide
  • Nationwide

Main finding

As reported in the abstract

Predictors of 5-year fatigue (multivariable linear regression)
Fatigue at year one (β)
0.66
Fatigue at year one, P
p < 0.001
Worse mental health at year one (β)
−0.41
Worse mental health at year one, P
p < 0.001

Observational data: associations, not effects.

Further findings

Univariable early predictors of 5-year fatigue

Significant predictors: more comorbidities, higher body mass index (BMI), more bodily pain, worse mental health, more early fatigue, more sleep disturbance, negative view of life after DTC diagnosis, greater fear of cancer recurrence

TSH and fatigue (linear mixed models)

TSH not a significant predictor of fatigue
P = 0.161

Original publication

Predictors of Long-Term Fatigue in Patients with Differentiated Thyroid Cancer: A Nationwide Prospective Study. Thyroid. Published 19 August 2026. doi:10.1177/10507256261479260

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.